Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study

about

Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.

P2860

Q33404709-7A12315D-037E-4F08-8615-C560E55CF68E

P2860

Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study

Item

http://www.wikidata.org/entity/Q58375689

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2011

@uk

name

Randomized trial of fondaparin ...... grafting: the Fonda CABG study

@en

Randomized trial of fondaparin ...... grafting: the Fonda CABG study

@nl

type

Item

label

Randomized trial of fondaparin ...... grafting: the Fonda CABG study

@en

Randomized trial of fondaparin ...... grafting: the Fonda CABG study

@nl

prefLabel

Randomized trial of fondaparin ...... grafting: the Fonda CABG study

@en

Randomized trial of fondaparin ...... grafting: the Fonda CABG study

@nl

P1476

Randomized trial of fondaparin ...... grafting: the Fonda CABG study

@en

P2093

Andre Lamy

http://www.w3.org/2001/XMLSchema#string

David Landry

http://www.w3.org/2001/XMLSchema#string

Hyejung Jung

http://www.w3.org/2001/XMLSchema#string

Jack C. J. Sun

http://www.w3.org/2001/XMLSchema#string

Kevin H. T. Teoh

http://www.w3.org/2001/XMLSchema#string

Tej Sheth

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting

Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance

Patency of coronary artery bypass grafts in patients with heparin-induced thrombocytopenia.

Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.

Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome.

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Treatment of heparin-induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux.

Recognition of the importance of embolization in atherosclerotic vascular disease.

Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention.

Postoperative development of aspirin resistance following coronary artery bypass.

P2888

s11239-011-0613-6

P304

378-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-011-0613-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salim Yusuf

John W. Eikelboom

Theodore E Warkentin

P577

2011-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21748448

http://www.w3.org/2001/XMLSchema#string

P921

coronary artery bypass surgery

Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study

about

P2860

P2860

Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921